José Mandojana
From this contributor
A new look at walking in early childhood: Q&A with Rujuta Wilson
Quantifying toddlers’ gaits promises to improve autism diagnosis and intervention.
A new look at walking in early childhood: Q&A with Rujuta Wilson
Catherine Lord: Lessons from a storied career in autism research
Catherine Lord's career has been defined by relationships: with mentors, protegees and, above all, with autistic people and their families.
Catherine Lord: Lessons from a storied career in autism research
Beyond the bench: A conversation with Michael Gandal
Michael Gandal, who studies the genetics of brain conditions, offers unusual advice on team building: Lock everyone up in a room together.
Beyond the bench: A conversation with Michael Gandal
Explore more from The Transmitter
Double-duty neurons in primary olfactory cortex pick up on more than just scent
The cells recognize not only odors, such as bananas and black licorice—but also images and words associated with those smells, according to single-neuron recordings from 17 people.
Double-duty neurons in primary olfactory cortex pick up on more than just scent
The cells recognize not only odors, such as bananas and black licorice—but also images and words associated with those smells, according to single-neuron recordings from 17 people.
How neuroscience comics add KA-POW! to the field: Q&A with Kanaka Rajan
The artistic approach can help explain complex ideas frame by frame without diluting the science, Rajan says.
How neuroscience comics add KA-POW! to the field: Q&A with Kanaka Rajan
The artistic approach can help explain complex ideas frame by frame without diluting the science, Rajan says.
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.